0001439222-21-000060.txt : 20210623
0001439222-21-000060.hdr.sgml : 20210623
20210623172844
ACCESSION NUMBER: 0001439222-21-000060
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210621
FILED AS OF DATE: 20210623
DATE AS OF CHANGE: 20210623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alenson Carman
CENTRAL INDEX KEY: 0001688865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 211039547
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20080703
4
1
wf-form4_162448370684332.xml
FORM 4
X0306
4
2021-06-21
0
0001439222
AGIOS PHARMACEUTICALS, INC.
AGIO
0001688865
Alenson Carman
C/O AGIOS PHARMACEUTICALS INC.
88 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Principal Accounting Officer
Common stock
2021-06-21
4
M
0
1777
51.51
A
1777
D
Common stock
2021-06-21
4
S
0
1777
61.61
D
0
D
Stock option (right to buy)
51.51
2021-06-21
4
M
0
1777
0
D
2030-02-14
Common stock
1777.0
3555
D
This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
/s/ William Cook as attorney-in-fact for Carman Alenson
2021-06-23